Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ultra-Rapid-Acting Insulin Lispro in T1DM
NCT02206568Phase 1Withdrawn
- Start
- Jun 2014
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised trial of insulin lispro in type 1 diabetes mellitus (T1D). Primary endpoint: Pharmacokinetics of URAL at 1 day. Planned start Jun 2014; status: withdrawn.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02206568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206568.